39. Appl Radiat Isot. 2018 Jul 29;140:278-288. doi: 10.1016/j.apradiso.2018.07.032.[Epub ahead of print]Comparison of [18F]Fluorocholine and [18F]Fluordesoxyglucose for assessment ofprogression, lung metastasis detection and therapy response in murine 4T1 breast tumor model.de Almeida Schirmer BG(1), de Araujo MR(1), Silveira MB(1), Pereira JM(1), VieiraLC(2), Alves CG(1), Mbolela WT(1), Ferreira AV(1), Silva-Cunha A(3), FialhoSL(4), da Silva JB(1), Malamut C(5).Author information: (1)Unidade de Pesquisa e Produção de Radiofármacos, Centro de Desenvolvimento da Tecnologia Nuclear (CDTN), Belo Horizonte, Brazil.(2)Faculdade de Farmácia - Universidade Federal de Minas Gerais (UFMG), BeloHorizonte, Brazil; Fundação Ezequiel Dias (FUNED), Belo Horizonte, Brazil.(3)Faculdade de Farmácia - Universidade Federal de Minas Gerais (UFMG), BeloHorizonte, Brazil.(4)Fundação Ezequiel Dias (FUNED), Belo Horizonte, Brazil.(5)Unidade de Pesquisa e Produção de Radiofármacos, Centro de Desenvolvimento da Tecnologia Nuclear (CDTN), Belo Horizonte, Brazil. Electronic address:malamut@cdtn.br.The [18F]Fluorocholine ([18F]FCH) tracer for PET imaging has been proven to beeffective for several malignances. However, there are only a few studies related to its breast tumor applicability and they are still limited. The aim of thisstudy was investigate the efficacy of [18F]FCH/PET compared to [18F]FDG/PET in a murine 4T1 mammary carcinoma model treated and nontreated. [18F]FCH/PET showedits applicability for primary tumor and lung metastasis detection and their usefor response monitoring of breast cancer therapeutics at earlier stages.Copyright © 2018 Elsevier Ltd. All rights reserved.DOI: 10.1016/j.apradiso.2018.07.032 PMID: 30081351 